Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

NCT07707778 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)
Metabolic Dysfunction Associated Steatotic Liver Disease
Dyslipidaemia
Diabetes Mellitus
Obesity & Overweight
Metabolic Syndrome

Interventions

DRUG: Tirzepatide

Sponsor

National Taiwan University Clinical Trial Center